Back to search
pMN
Clinical trial pipeline · Data from ClinicalTrials.gov
See which pMN trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which pMN trials you may qualify forIn this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with P…
This research study involves the study of granulocyte colony stimulating factor (G-CSF) in patients with MGMT-methylated glioblastoma multiforme (GBM) that are…
To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
Bone marrow transplants (BMT) are one form of treatment for disorders of the blood, including leukemia. However, because the procedure is often associated with…
Gene therapy is a new possible treatment for the anemia of DBAS. Gene therapy will soon be available for patients with RPS19-mutated DBAS. This involves inserti…
Background: CGD is caused by a gene mutation. For people with CGD, their cells cannot kill germs well, so they can get frequent or life-threatening infections.…
The primary purpose of this study is to determine complete remission rate of a novel combination induction chemotherapy treatment based upon 20 patients with ne…
The primary objective is to investigate whether treatment with Adacolumn can ameliorate the progression of cerebral edema within 72 hours in patients with anter…